In this special edition of Ethics Talk, Dr Uché Blackstock joins us to discuss COVID-19 morbidity and mortality outcomes inequity by race and what needs to change now and postpandemic. Transcript available.
Jennifer D. Byrne, LCSW, CADC, Katie S. Clancy, MSW, and Isabell Ciszewski, LCSW
Social work perspectives on whether prescribers should authorize opioid refills emphasize the importance of multidisciplinary approaches to patient self-determination.
AMA J Ethics. 2020;22(8):E658-663. doi:
10.1001/amajethics.2020.658.
Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key.
AMA J Ethics. 2020;22(8):E668-674. doi:
10.1001/amajethics.2020.668.
Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful.
AMA J Ethics. 2020;22(8):E723-728. doi:
10.1001/amajethics.2020.723.
Dr Margaret M. Sullivan joins Ethics Talk to discuss her article, coauthored with Emily E. Lazowy, Dr Jill S. Roncarati, Dr Howard K. Koh, and Dr James J. O’Connell: “Training Clinicians to Care for Patients Where They Are."
Successful implementation of initiatives to improve screening and access to health-promotion activities at minority-serving religious institutions requires partnering with faith-based organizations, adapting interventions, and leveraging organizational infrastructure and social networks.
AMA J Ethics. 2018;20(7):E643-654. doi:
10.1001/amajethics.2018.643.